US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Chemomab Therapeutics Ltd.

1.57

+0.01000.64%

Volume:10.01K

Turnover:15.89K

Market Cap:9.66M

PE:-0.94

High:1.62

Open:1.62

Low:1.55

Close:1.56

52wk High:8.25

52wk Low:1.42

Shares:6.16M

Float Shares:5.01M

Volume Ratio:0.60

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6725

EPS(LYR):-3.1071

ROE:-73.21%

ROA:-40.61%

PB:0.86

PE(LYR):-0.51

Loading ...

Overview Company News Filings

BRIEF-Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results

Chemomab Therapeutics Publishes Positive Phase 2 Results for Nebokitug in Primary Sclerosing Cholangitis

Chemomab Therapeutics CEO to Present at Oppenheimer Movers in Rare Disease Summit

Chemomab Therapeutics (CMMB) Gets a Buy from Oppenheimer

BRIEF-Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update

Chemomab Therapeutics Ltd - Cash Runway Expected Through End of Q4 2026

THOMSON REUTERS

Press Release: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Chemomab Reports Positive Phase 2 Data for Nebokitug in Primary Sclerosing Cholangitis

Chemomab Announces Multiple Presentations at Aasld the Liver Meeting® 2025 Featuring Clinical Data From the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis

THOMSON REUTERS

Chemomab Therapeutics Announces 1-for-4 Reverse ADS Split Effective August 2025

Chemomab Therapeutics Ltd. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Chemomab Therapeutics Ltd - to Change Ads Ratio to 1:80 Ordinary Shares Effective August 26

THOMSON REUTERS

Chemomab Therapeutics Ltd. Conducted Annual General Shareholders Meeting

Chemomab Therapeutics Announces Positive Phase 2 Trial Results for Nebokitug, Advancing Towards Phase 3 for Primary Sclerosing Cholangitis Treatment

Chemomab Therapeutics Secures FDA Alignment on CMC and Toxicology Milestones, Advancing Phase 3 Development of Nebokitug for PSC

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CMMB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMMB\",,,,,undefined,":{"symbol":"CMMB","market":"US","secType":"STK","nameCN":"Chemomab Therapeutics Ltd.","latestPrice":1.57,"timestamp":1770825761949,"preClose":1.56,"halted":0,"volume":10013,"delay":0,"changeRate":0.006410256410256416,"floatShares":5006400,"shares":6155116,"eps":-1.672458,"marketStatus":"Trading","change":0.01,"latestTime":"02-11 11:07:47 EST","open":1.62,"high":1.62,"low":1.55,"amount":15889.8119366,"amplitude":0.044872,"askPrice":1.59,"askSize":300,"bidPrice":1.56,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.672458,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"adrRate":80,"listingDate":1549947600000,"exchange":"NASDAQ","adjPreClose":1.56,"postHourTrading":{"tag":"盘后","latestPrice":1.56,"preClose":1.56,"latestTime":"19:11 EST","volume":3461,"amount":5400.72,"timestamp":1770768696404,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.599252},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMMB\",,,,,undefined,":{"symbol":"CMMB","floatShares":5006400,"roa":"-40.61%","roe":"-73.21%","lyrEps":-3.107099,"volumeRatio":0.599252,"shares":6155116,"dividePrice":0,"high":1.62,"amplitude":0.044872,"preClose":1.56,"low":1.55,"week52Low":1.42,"pbRate":"0.86","week52High":8.248,"institutionHeld":0,"latestPrice":1.57,"committee":-0.2,"eps":-1.672458,"divideRate":0,"volume":10013,"delay":0,"ttmEps":-1.672458,"open":1.62,"prevYearClose":1.65,"prevWeekClose":1.5303,"prevMonthClose":1.55,"prevQuarterClose":1.65,"fiveDayClose":1.63,"twentyDayClose":1.79,"sixtyDayClose":2.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMMB\",params:#limit:5,,,undefined,":[{"date":"2025-11-20","symbol":"CMMB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763629200000,"name":null,"time":"Pre-Market","dateTimestamp":1763614800000,"actualEps":null},{"market":"US","date":"2025-08-26","symbol":"CMMB","defaultRemindTime":1756215000000,"type":"split","dateTimestamp":1756180800000,"forFactor":4,"toFactor":1,"ratio":4},{"market":"US","date":"2025-08-14","symbol":"CMMB","fiscalQuarterEnding":"2025/06","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2025-05-15","symbol":"CMMB","fiscalQuarterEnding":"2025/03","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-03-03","symbol":"CMMB","fiscalQuarterEnding":"2024/12","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1755579600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMMB","date":"2026-02-09","current":-0.932759,"percent":0.707358,"low":-98.872227,"twenty":-4.894769,"median":-1.503229,"eighty":-0.602621,"high":58.769136,"avg":-6.005004,"sd":12.737004,"marketCap":9419174},"quantilePoints":[{"date":"2021-03-19","current":-91.519729,"twenty":-35.539936,"median":48.429753,"eighty":54.633383,"marketCap":544633907},{"date":"2021-03-26","current":-55.781913,"twenty":-75.955442,"median":-57.552625,"eighty":6.745087,"marketCap":331958164},{"date":"2021-04-01","current":-50.766395,"twenty":-63.6845,"median":-54.253888,"eighty":-50.935377,"marketCap":302110814},{"date":"2021-04-09","current":-82.513368,"twenty":-79.007898,"median":-52.725862,"eighty":-48.975909,"marketCap":491037052},{"date":"2021-04-16","current":-49.004772,"twenty":-71.281483,"median":-56.204367,"eighty":-49.19171,"marketCap":291627398},{"date":"2021-04-23","current":-61.121139,"twenty":-69.57369,"median":-56.626821,"eighty":-50.104849,"marketCap":363731898},{"date":"2021-04-30","current":-53.139437,"twenty":-64.691225,"median":-57.669532,"eighty":-50.935377,"marketCap":316232791},{"date":"2021-05-07","current":-35.648005,"twenty":-63.397002,"median":-55.781913,"eighty":-48.78897,"marketCap":212141280},{"date":"2021-05-14","current":-30.514421,"twenty":-62.857698,"median":-53.74166,"eighty":-36.852451,"marketCap":181865949},{"date":"2021-05-21","current":-31.196508,"twenty":-62.433446,"median":-51.73714,"eighty":-34.423856,"marketCap":185931187},{"date":"2021-05-28","current":-31.770897,"twenty":-61.919309,"median":-50.550725,"eighty":-31.311386,"marketCap":189354546},{"date":"2021-06-04","current":-32.452984,"twenty":-61.588536,"median":-49.472118,"eighty":-30.848198,"marketCap":193419785},{"date":"2021-06-11","current":-42.935585,"twenty":-61.570559,"median":-46.829482,"eighty":-31.196508,"marketCap":255896088},{"date":"2021-06-18","current":-38.104027,"twenty":-61.121139,"median":-42.083702,"eighty":-31.250357,"marketCap":227100000},{"date":"2021-06-25","current":-38.307101,"twenty":-60.366113,"median":-41.39013,"eighty":-31.770897,"marketCap":228310320},{"date":"2021-07-02","current":-34.76254,"twenty":-58.478428,"median":-40.587065,"eighty":-32.322296,"marketCap":207184738},{"date":"2021-07-09","current":-34.984075,"twenty":-57.184194,"median":-39.848616,"eighty":-32.29343,"marketCap":208505087},{"date":"2021-07-16","current":-33.839477,"twenty":-56.673584,"median":-38.307101,"eighty":-32.29343,"marketCap":201683285},{"date":"2021-07-23","current":-32.731802,"twenty":-55.950895,"median":-36.540142,"eighty":-32.426846,"marketCap":195081541},{"date":"2021-07-30","current":-30.701064,"twenty":-54.861592,"median":-35.683959,"eighty":-31.801171,"marketCap":182978343},{"date":"2021-08-06","current":-30.257994,"twenty":-54.401409,"median":-35.427145,"eighty":-31.125673,"marketCap":180337645},{"date":"2021-08-13","current":-22.113138,"twenty":-53.380326,"median":-35.055685,"eighty":-30.686295,"marketCap":169143396},{"date":"2021-08-20","current":-18.134562,"twenty":-52.808577,"median":-34.734848,"eighty":-30.547239,"marketCap":138711262},{"date":"2021-08-27","current":-23.543638,"twenty":-51.934884,"median":-34.553094,"eighty":-30.2621,"marketCap":180085287},{"date":"2021-09-03","current":-21.830019,"twenty":-51.63647,"median":-34.004385,"eighty":-29.866616,"marketCap":166977813},{"date":"2021-09-10","current":-20.921056,"twenty":-51.104358,"median":-33.811785,"eighty":-29.763523,"marketCap":160025154},{"date":"2021-09-17","current":-19.356447,"twenty":-50.507592,"median":-33.72871,"eighty":-23.209855,"marketCap":148057460},{"date":"2021-09-24","current":-17.940848,"twenty":-50.0977,"median":-33.451791,"eighty":-22.083336,"marketCap":137229548},{"date":"2021-10-01","current":-16.09312,"twenty":-49.378648,"median":-32.787186,"eighty":-21.645246,"marketCap":123096272},{"date":"2021-10-08","current":-13.79836,"twenty":-48.842921,"median":-32.38764,"eighty":-20.041894,"marketCap":105543655},{"date":"2021-10-15","current":-13.545042,"twenty":-47.591697,"median":-32.177965,"eighty":-19.326645,"marketCap":103606029},{"date":"2021-10-22","current":-15.184156,"twenty":-44.493144,"median":-31.510627,"eighty":-18.820009,"marketCap":116143612},{"date":"2021-10-29","current":-14.971519,"twenty":-42.758824,"median":-31.144134,"eighty":-18.268671,"marketCap":114517146},{"date":"2021-11-05","current":-14.543412,"twenty":-42.16739,"median":-30.783862,"eighty":-18.057076,"marketCap":111242557},{"date":"2021-11-12","current":-11.785515,"twenty":-41.656517,"median":-30.627219,"eighty":-16.67426,"marketCap":110701340},{"date":"2021-11-19","current":-11.190777,"twenty":-41.444646,"median":-30.586219,"eighty":-15.443434,"marketCap":105114970},{"date":"2021-11-26","current":-10.765965,"twenty":-41.153826,"median":-30.524667,"eighty":-15.011304,"marketCap":101124705},{"date":"2021-12-03","current":-9.273052,"twenty":-40.769832,"median":-30.263126,"eighty":-14.901037,"marketCap":87101775},{"date":"2021-12-10","current":-9.697864,"twenty":-40.614757,"median":-30.137996,"eighty":-14.716264,"marketCap":91092040},{"date":"2021-12-17","current":-8.119989,"twenty":-40.24184,"median":-29.851847,"eighty":-14.22751,"marketCap":76271057},{"date":"2021-12-23","current":-9.151677,"twenty":-39.898461,"median":-29.778485,"eighty":-14.030817,"marketCap":85961700},{"date":"2021-12-31","current":-8.374877,"twenty":-39.710156,"median":-29.015625,"eighty":-13.774518,"marketCap":78665216},{"date":"2022-01-07","current":-8.171232,"twenty":-39.252317,"median":-22.70918,"eighty":-13.5212,"marketCap":76752379},{"date":"2022-01-14","current":-7.989109,"twenty":-38.266486,"median":-22.209995,"eighty":-11.707835,"marketCap":75041702},{"date":"2022-01-21","current":-6.54427,"twenty":-38.104027,"median":-21.98648,"eighty":-11.020852,"marketCap":61470330},{"date":"2022-01-28","current":-5.73079,"twenty":-37.180964,"median":-21.830019,"eighty":-10.620315,"marketCap":53829306},{"date":"2022-02-04","current":-5.524384,"twenty":-35.899319,"median":-20.950858,"eighty":-9.843514,"marketCap":51890538},{"date":"2022-02-11","current":-5.281554,"twenty":-35.881369,"median":-19.997191,"eighty":-9.564352,"marketCap":49609635},{"date":"2022-02-18","current":-4.68662,"twenty":-35.683959,"median":-19.468204,"eighty":-9.151677,"marketCap":44021424},{"date":"2022-02-25","current":-4.905167,"twenty":-35.655196,"median":-19.095678,"eighty":-8.816682,"marketCap":46074236},{"date":"2022-03-04","current":-4.832318,"twenty":-35.500855,"median":-18.849811,"eighty":-8.469356,"marketCap":45389965},{"date":"2022-03-11","current":-3.838673,"twenty":-35.404992,"median":-18.440033,"eighty":-8.377085,"marketCap":47898958},{"date":"2022-03-18","current":-4.094584,"twenty":-35.168688,"median":-18.223968,"eighty":-8.190926,"marketCap":51092222},{"date":"2022-03-25","current":-4.551569,"twenty":-35.067209,"median":-18.134562,"eighty":-7.9813,"marketCap":56794479},{"date":"2022-04-01","current":-4.414474,"twenty":-34.998397,"median":-17.806739,"eighty":-7.073639,"marketCap":55083807},{"date":"2022-04-08","current":-3.756416,"twenty":-34.806847,"median":-16.659359,"eighty":-6.204308,"marketCap":46872556},{"date":"2022-04-14","current":-3.482225,"twenty":-34.72931,"median":-16.301735,"eighty":-5.920197,"marketCap":43451202},{"date":"2022-04-22","current":-3.098358,"twenty":-34.657798,"median":-15.184156,"eighty":-5.670082,"marketCap":38661305},{"date":"2022-04-29","current":-2.879005,"twenty":-34.581814,"median":-15.020245,"eighty":-5.478246,"marketCap":35924222},{"date":"2022-05-06","current":-2.769328,"twenty":-34.456166,"median":-14.94574,"eighty":-5.310694,"marketCap":34555680},{"date":"2022-05-13","current":-2.003871,"twenty":-34.163888,"median":-14.878685,"eighty":-5.05815,"marketCap":31817456},{"date":"2022-05-20","current":-2.169142,"twenty":-34.002839,"median":-14.752026,"eighty":-4.844835,"marketCap":34441635},{"date":"2022-05-27","current":-2.176324,"twenty":-33.902348,"median":-14.580665,"eighty":-4.626514,"marketCap":34555680},{"date":"2022-06-03","current":-2.434898,"twenty":-33.817324,"median":-14.237941,"eighty":-4.492371,"marketCap":38661305},{"date":"2022-06-10","current":-2.715019,"twenty":-33.769325,"median":-14.066579,"eighty":-4.410209,"marketCap":43109066},{"date":"2022-06-17","current":-2.38462,"twenty":-33.739787,"median":-13.880316,"eighty":-4.319081,"marketCap":37862989},{"date":"2022-06-24","current":-2.944862,"twenty":-33.713941,"median":-13.783459,"eighty":-4.118347,"marketCap":46758511},{"date":"2022-07-01","current":-2.38462,"twenty":-33.643788,"median":-13.559943,"eighty":-3.866092,"marketCap":37862989},{"date":"2022-07-08","current":-2.485176,"twenty":-33.599481,"median":-13.51524,"eighty":-3.756416,"marketCap":39459621},{"date":"2022-07-15","current":-2.269698,"twenty":-33.304101,"median":-11.785515,"eighty":-3.62846,"marketCap":36038267},{"date":"2022-07-22","current":-2.327159,"twenty":-33.008721,"median":-11.22719,"eighty":-3.463945,"marketCap":36950628},{"date":"2022-07-29","current":-2.19069,"twenty":-32.787186,"median":-10.966233,"eighty":-3.116637,"marketCap":34783770},{"date":"2022-08-05","current":-2.513906,"twenty":-32.731802,"median":-10.765965,"eighty":-2.94127,"marketCap":39915802},{"date":"2022-08-12","current":-2.369501,"twenty":-32.452984,"median":-10.371496,"eighty":-2.888144,"marketCap":45726624},{"date":"2022-08-19","current":-1.978533,"twenty":-32.322296,"median":-9.843514,"eighty":-2.860251,"marketCap":38181731},{"date":"2022-08-26","current":-1.990381,"twenty":-32.177965,"median":-9.637176,"eighty":-2.779662,"marketCap":38410364},{"date":"2022-09-02","current":-2.008152,"twenty":-32.177965,"median":-9.479389,"eighty":-2.679106,"marketCap":38753313},{"date":"2022-09-09","current":-2.049618,"twenty":-31.882584,"median":-9.273052,"eighty":-2.612619,"marketCap":39553529},{"date":"2022-09-16","current":-1.777126,"twenty":-31.778465,"median":-8.927133,"eighty":-2.564697,"marketCap":34294968},{"date":"2022-09-23","current":-1.463167,"twenty":-31.354465,"median":-8.739002,"eighty":-2.498104,"marketCap":28236190},{"date":"2022-09-30","current":-1.475014,"twenty":-31.207278,"median":-8.515854,"eighty":-2.472247,"marketCap":28464823},{"date":"2022-10-07","current":-1.380234,"twenty":-31.154609,"median":-8.414062,"eighty":-2.410477,"marketCap":26635758},{"date":"2022-10-14","current":-1.18475,"twenty":-31.070289,"median":-8.376257,"eighty":-2.383874,"marketCap":22863312},{"date":"2022-10-21","current":-1.18475,"twenty":-30.888924,"median":-8.219798,"eighty":-2.366779,"marketCap":22863312},{"date":"2022-10-28","current":-1.19956,"twenty":-30.74526,"median":-8.177302,"eighty":-2.332598,"marketCap":23149103},{"date":"2022-11-04","current":-1.18475,"twenty":-30.704756,"median":-7.989109,"eighty":-2.268262,"marketCap":22863312},{"date":"2022-11-11","current":-0.982108,"twenty":-30.641988,"median":-7.738926,"eighty":-2.226603,"marketCap":23973258},{"date":"2022-11-18","current":-0.98683,"twenty":-30.623139,"median":-6.568553,"eighty":-2.207222,"marketCap":24088514},{"date":"2022-11-25","current":-0.973845,"twenty":-30.622119,"median":-6.337865,"eighty":-2.187817,"marketCap":23771560},{"date":"2022-12-02","current":-1.038768,"twenty":-30.57904,"median":-6.05861,"eighty":-2.171771,"marketCap":25356331},{"date":"2022-12-09","current":-1.133202,"twenty":-30.541076,"median":-5.876487,"eighty":-2.146158,"marketCap":27661452},{"date":"2022-12-16","current":-0.963221,"twenty":-30.522618,"median":-5.700436,"eighty":-2.044879,"marketCap":23512234},{"date":"2022-12-23","current":-1.114315,"twenty":-30.382719,"median":-5.597233,"eighty":-2.00644,"marketCap":27200427},{"date":"2022-12-30","current":-1.510936,"twenty":-30.282201,"median":-5.512242,"eighty":-1.983272,"marketCap":36881936},{"date":"2023-01-06","current":-1.067098,"twenty":-30.2621,"median":-5.41511,"eighty":-1.948914,"marketCap":26047867},{"date":"2023-01-13","current":-1.067098,"twenty":-30.239533,"median":-5.305837,"eighty":-1.937067,"marketCap":26047867},{"date":"2023-01-20","current":-1.067098,"twenty":-30.165688,"median":-5.269412,"eighty":-1.931143,"marketCap":26047867},{"date":"2023-01-27","current":-0.982108,"twenty":-30.110304,"median":-5.050865,"eighty":-1.853108,"marketCap":23973258},{"date":"2023-02-03","current":-1.048212,"twenty":-29.870308,"median":-4.879173,"eighty":-1.605337,"marketCap":25586843},{"date":"2023-02-10","current":-0.977386,"twenty":-29.851847,"median":-4.747328,"eighty":-1.480938,"marketCap":23858002},{"date":"2023-02-17","current":-0.925448,"twenty":-29.850284,"median":-4.624687,"eighty":-1.427624,"marketCap":22590185},{"date":"2023-02-24","current":-0.691463,"twenty":-29.792845,"median":-4.539264,"eighty":-1.380234,"marketCap":19116174},{"date":"2023-03-03","current":-0.671478,"twenty":-29.74856,"median":-4.460173,"eighty":-1.350616,"marketCap":18563684},{"date":"2023-03-10","current":-0.59154,"twenty":-29.297133,"median":-4.41092,"eighty":-1.241662,"marketCap":16353721},{"date":"2023-03-17","current":-0.587543,"twenty":-28.913312,"median":-4.377915,"eighty":-1.213184,"marketCap":16243223},{"date":"2023-03-24","current":-0.6435,"twenty":-24.603931,"median":-4.285951,"eighty":-1.204298,"marketCap":17790197},{"date":"2023-03-31","current":-0.635506,"twenty":-22.876072,"median":-4.094584,"eighty":-1.196586,"marketCap":17569201},{"date":"2023-04-06","current":-0.571556,"twenty":-22.530367,"median":-3.902651,"eighty":-1.18475,"marketCap":15801231},{"date":"2023-04-14","current":-0.631509,"twenty":-22.348575,"median":-3.847812,"eighty":-1.176457,"marketCap":17458702},{"date":"2023-04-21","current":-0.631509,"twenty":-22.190624,"median":-3.756416,"eighty":-1.136035,"marketCap":17458702},{"date":"2023-04-28","current":-0.611525,"twenty":-22.068435,"median":-3.669588,"eighty":-1.107705,"marketCap":16906212},{"date":"2023-05-05","current":-0.575553,"twenty":-21.976049,"median":-3.591901,"eighty":-1.091651,"marketCap":15911729},{"date":"2023-05-12","current":-0.645498,"twenty":-21.904524,"median":-3.482225,"eighty":-1.080319,"marketCap":17845446},{"date":"2023-05-19","current":-0.649677,"twenty":-21.8479,"median":-3.422817,"eighty":-1.070403,"marketCap":20331654},{"date":"2023-05-26","current":-0.57906,"twenty":-21.645246,"median":-3.116637,"eighty":-1.067098,"marketCap":18121691},{"date":"2023-06-02","current":-0.564937,"twenty":-21.290602,"median":-2.980774,"eighty":-1.057655,"marketCap":17679699},{"date":"2023-06-09","current":-0.6179,"twenty":-20.968739,"median":-2.932987,"eighty":-1.044434,"marketCap":19337171},{"date":"2023-06-15","current":-0.600245,"twenty":-20.921056,"median":-2.919439,"eighty":-1.034046,"marketCap":18784680},{"date":"2023-06-23","current":-0.473135,"twenty":-20.241568,"median":-2.883574,"eighty":-1.018937,"marketCap":14806748},{"date":"2023-06-30","current":-0.430764,"twenty":-20.026993,"median":-2.869865,"eighty":-0.989663,"marketCap":13480770},{"date":"2023-07-07","current":-0.459011,"twenty":-19.913745,"median":-2.851348,"eighty":-0.982108,"marketCap":14364755},{"date":"2023-07-14","current":-0.49432,"twenty":-19.705131,"median":-2.822757,"eighty":-0.977386,"marketCap":15469736},{"date":"2023-07-21","current":-0.480196,"twenty":-19.490556,"median":-2.763721,"eighty":-0.967943,"marketCap":15027744},{"date":"2023-07-28","current":-0.45548,"twenty":-19.341546,"median":-2.697062,"eighty":-0.963221,"marketCap":14254257},{"date":"2023-08-04","current":-0.441357,"twenty":-19.207436,"median":-2.650375,"eighty":-0.95,"marketCap":13812265},{"date":"2023-08-11","current":-0.416641,"twenty":-18.903456,"median":-2.603688,"eighty":-0.926392,"marketCap":13038778},{"date":"2023-08-18","current":-0.350788,"twenty":-18.873653,"median":-2.577395,"eighty":-0.820525,"marketCap":11602302},{"date":"2023-08-25","current":-0.371693,"twenty":-18.83491,"median":-2.513906,"eighty":-0.685068,"marketCap":12293748},{"date":"2023-09-01","current":-0.396711,"twenty":-18.775306,"median":-2.49595,"eighty":-0.671478,"marketCap":13121212},{"date":"2023-09-08","current":-0.375267,"twenty":-18.596494,"median":-2.485176,"eighty":-0.653892,"marketCap":12411957},{"date":"2023-09-15","current":-0.382415,"twenty":-18.432582,"median":-2.463628,"eighty":-0.647497,"marketCap":12648375},{"date":"2023-09-22","current":-0.375267,"twenty":-18.361057,"median":-2.434898,"eighty":-0.647497,"marketCap":12411957},{"date":"2023-09-27","current":-0.332236,"twenty":-18.319334,"median":-2.424124,"eighty":-0.647097,"marketCap":10988719},{"date":"2023-10-06","current":-0.297676,"twenty":-18.238869,"median":-2.391802,"eighty":-0.639503,"marketCap":9845637},{"date":"2023-10-13","current":-0.31987,"twenty":-18.197146,"median":-2.38462,"eighty":-0.635506,"marketCap":10579716},{"date":"2023-10-20","current":-0.300214,"twenty":-18.152443,"median":-2.373845,"eighty":-0.631509,"marketCap":9929566},{"date":"2023-10-27","current":-0.293209,"twenty":-18.134562,"median":-2.369878,"eighty":-0.631509,"marketCap":9697876},{"date":"2023-11-03","current":-0.271479,"twenty":-18.134562,"median":-2.348707,"eighty":-0.623515,"marketCap":8979164},{"date":"2023-11-10","current":-0.214438,"twenty":-17.940848,"median":-2.330558,"eighty":-0.619518,"marketCap":7092547},{"date":"2023-11-17","current":-0.268324,"twenty":-17.806739,"median":-2.284063,"eighty":-0.615522,"marketCap":7801801},{"date":"2023-11-24","current":-0.225636,"twenty":-17.38951,"median":-2.262516,"eighty":-0.611525,"marketCap":6560606},{"date":"2023-12-01","current":-0.219132,"twenty":-16.844132,"median":-2.23375,"eighty":-0.607528,"marketCap":6371471},{"date":"2023-12-08","current":-0.195186,"twenty":-16.614656,"median":-2.212237,"eighty":-0.602874,"marketCap":5675219},{"date":"2023-12-15","current":-0.20287,"twenty":-16.52525,"median":-2.203715,"eighty":-0.59911,"marketCap":5898635},{"date":"2023-12-22","current":-0.199211,"twenty":-16.176566,"median":-2.19069,"eighty":-0.595537,"marketCap":5792246},{"date":"2023-12-29","current":-0.215473,"twenty":-15.902386,"median":-2.179915,"eighty":-0.59154,"marketCap":6265083},{"date":"2024-01-05","current":-0.215473,"twenty":-15.616286,"median":-2.176324,"eighty":-0.583546,"marketCap":6265083},{"date":"2024-01-12","current":-0.227588,"twenty":-15.184156,"median":-2.169142,"eighty":-0.575553,"marketCap":6617346},{"date":"2024-01-19","current":-0.217912,"twenty":-15.136473,"median":-2.154777,"eighty":-0.57191,"marketCap":6336008},{"date":"2024-01-26","current":-0.20413,"twenty":-15.076869,"median":-2.114779,"eighty":-0.557875,"marketCap":5935279},{"date":"2024-02-02","current":-0.231491,"twenty":-14.993423,"median":-2.043694,"eighty":-0.501381,"marketCap":6730827},{"date":"2024-02-09","current":-0.243931,"twenty":-14.972324,"median":-2.011125,"eighty":-0.494052,"marketCap":7092547},{"date":"2024-02-16","current":-0.247997,"twenty":-14.950896,"median":-2.00305,"eighty":-0.485846,"marketCap":7210756},{"date":"2024-02-23","current":-0.304914,"twenty":-14.932329,"median":-1.984457,"eighty":-0.475253,"marketCap":8865684},{"date":"2024-03-01","current":-0.278488,"twenty":-14.901037,"median":-1.948914,"eighty":-0.459011,"marketCap":8097324},{"date":"2024-03-08","current":-0.390435,"twenty":-14.877195,"median":-1.940029,"eighty":-0.451949,"marketCap":9456729},{"date":"2024-03-15","current":-0.486178,"twenty":-14.817591,"median":-1.937067,"eighty":-0.451949,"marketCap":11775725},{"date":"2024-03-22","current":-0.462661,"twenty":-14.763947,"median":-1.932624,"eighty":-0.451949,"marketCap":11206115},{"date":"2024-03-28","current":-0.451577,"twenty":-14.728184,"median":-1.922257,"eighty":-0.451601,"marketCap":10937645},{"date":"2024-04-05","current":-0.457442,"twenty":-14.66262,"median":-1.853108,"eighty":-0.451601,"marketCap":11079693},{"date":"2024-04-12","current":-0.445712,"twenty":-14.588115,"median":-1.655689,"eighty":-0.451601,"marketCap":10795598},{"date":"2024-04-19","current":-0.410525,"twenty":-14.442085,"median":-1.587565,"eighty":-0.446181,"marketCap":9943314},{"date":"2024-04-26","current":-0.38648,"twenty":-14.248371,"median":-1.495937,"eighty":-0.441357,"marketCap":9360920},{"date":"2024-05-03","current":-0.431168,"twenty":-14.162243,"median":-1.463167,"eighty":-0.433831,"marketCap":10443321},{"date":"2024-05-10","current":-0.475036,"twenty":-14.102788,"median":-1.412815,"eighty":-0.432294,"marketCap":11505835},{"date":"2024-05-17","current":-0.639125,"twenty":-14.048698,"median":-1.380234,"eighty":-0.43552,"marketCap":12358119},{"date":"2024-05-24","current":-0.61697,"twenty":-13.980153,"median":-1.37476,"eighty":-0.437826,"marketCap":11929739},{"date":"2024-05-31","current":-0.779486,"twenty":-13.902667,"median":-1.323959,"eighty":-0.438113,"marketCap":15072137},{"date":"2024-06-07","current":-0.838241,"twenty":-13.834122,"median":-1.249912,"eighty":-0.43968,"marketCap":16208235},{"date":"2024-06-14","current":-0.845669,"twenty":-13.79836,"median":-1.232357,"eighty":-0.441357,"marketCap":16351847},{"date":"2024-06-21","current":-0.683888,"twenty":-13.774518,"median":-1.222913,"eighty":-0.441357,"marketCap":13223668},{"date":"2024-06-28","current":-0.714039,"twenty":-13.732795,"median":-1.214369,"eighty":-0.441357,"marketCap":13806661},{"date":"2024-07-05","current":-0.711465,"twenty":-13.589745,"median":-1.208445,"eighty":-0.441357,"marketCap":13756880},{"date":"2024-07-12","current":-0.838315,"twenty":-13.559943,"median":-1.202522,"eighty":-0.441357,"marketCap":16209657},{"date":"2024-07-15","current":-0.815592,"twenty":-13.556963,"median":-1.19956,"eighty":-0.442228,"marketCap":15770290},{"date":"2024-08-02","current":-0.856699,"twenty":-13.553983,"median":-1.199412,"eighty":-0.443099,"marketCap":16565132},{"date":"2024-08-09","current":-0.742791,"twenty":-13.533121,"median":-1.196598,"eighty":-0.446181,"marketCap":14362609},{"date":"2024-08-16","current":-0.794193,"twenty":-13.061245,"median":-1.187712,"eighty":-0.44712,"marketCap":15356517},{"date":"2024-08-23","current":-1.15671,"twenty":-12.142357,"median":-1.18475,"eighty":-0.449067,"marketCap":17347177},{"date":"2024-08-30","current":-1.876643,"twenty":-11.785515,"median":-1.187712,"eighty":-0.451507,"marketCap":28144012},{"date":"2024-09-06","current":-2.192608,"twenty":-11.766095,"median":-1.196569,"eighty":-0.451589,"marketCap":32882545},{"date":"2024-09-13","current":-1.914942,"twenty":-11.59617,"median":-1.199263,"eighty":-0.451699,"marketCap":28718380},{"date":"2024-09-20","current":-1.608551,"twenty":-11.219907,"median":-1.206964,"eighty":-0.451949,"marketCap":24123439},{"date":"2024-09-27","current":-1.503229,"twenty":-11.156792,"median":-1.208445,"eighty":-0.451949,"marketCap":22543928},{"date":"2024-10-04","current":-1.445781,"twenty":-10.999005,"median":-1.224565,"eighty":-0.452015,"marketCap":21682376},{"date":"2024-10-11","current":-1.148965,"twenty":-10.88734,"median":-1.232357,"eighty":-0.452921,"marketCap":17231028},{"date":"2024-10-18","current":-1.225563,"twenty":-10.785385,"median":-1.22589,"eighty":-0.45548,"marketCap":18379763},{"date":"2024-10-25","current":-1.378758,"twenty":-10.736835,"median":-1.235137,"eighty":-0.455755,"marketCap":20677233},{"date":"2024-10-31","current":-1.359609,"twenty":-10.620315,"median":-1.249912,"eighty":-0.456855,"marketCap":20390049},{"date":"2024-11-08","current":-1.417057,"twenty":-10.45039,"median":-1.266908,"eighty":-0.457442,"marketCap":21251601},{"date":"2024-11-15","current":-1.665999,"twenty":-10.292602,"median":-1.32131,"eighty":-0.459011,"marketCap":24984990},{"date":"2024-11-22","current":-2.095324,"twenty":-10.231915,"median":-1.363998,"eighty":-0.459011,"marketCap":30170577},{"date":"2024-11-29","current":-2.383432,"twenty":-9.921194,"median":-1.369183,"eighty":-0.461931,"marketCap":34319032},{"date":"2024-12-06","current":-2.160803,"twenty":-9.756124,"median":-1.373971,"eighty":-0.462708,"marketCap":31113408},{"date":"2024-12-13","current":-2.213186,"twenty":-9.705147,"median":-1.378758,"eighty":-0.463189,"marketCap":31867672},{"date":"2024-12-20","current":-2.121516,"twenty":-9.600764,"median":-1.380234,"eighty":-0.463306,"marketCap":30547709},{"date":"2024-12-27","current":-2.60606,"twenty":-9.569207,"median":-1.380234,"eighty":-0.463517,"marketCap":37524655},{"date":"2025-01-03","current":-2.789401,"twenty":-9.530367,"median":-1.398005,"eighty":-0.464624,"marketCap":40164581},{"date":"2025-01-10","current":-2.907263,"twenty":-9.476962,"median":-1.417057,"eighty":-0.466165,"marketCap":41861676},{"date":"2025-01-17","current":-2.553677,"twenty":-9.428412,"median":-1.440994,"eighty":-0.466978,"marketCap":36770391},{"date":"2025-01-24","current":-2.776305,"twenty":-9.273052,"median":-1.445781,"eighty":-0.46876,"marketCap":39976015},{"date":"2025-01-31","current":-2.671539,"twenty":-9.151677,"median":-1.455356,"eighty":-0.469171,"marketCap":38467486},{"date":"2025-02-07","current":-2.737018,"twenty":-9.018164,"median":-1.469718,"eighty":-0.473135,"marketCap":39410316},{"date":"2025-02-14","current":-2.592964,"twenty":-8.836102,"median":-1.480938,"eighty":-0.473135,"marketCap":37336089},{"date":"2025-02-21","current":-2.317953,"twenty":-8.836102,"median":-1.503229,"eighty":-0.473248,"marketCap":33376201},{"date":"2025-02-28","current":-2.121516,"twenty":-8.758422,"median":-1.503229,"eighty":-0.474684,"marketCap":30547709},{"date":"2025-03-07","current":-2.001275,"twenty":-8.680742,"median":-1.510936,"eighty":-0.476339,"marketCap":27907784},{"date":"2025-03-14","current":-1.879576,"twenty":-8.578787,"median":-1.515197,"eighty":-0.47949,"marketCap":26210689},{"date":"2025-03-21","current":-1.825488,"twenty":-8.491203,"median":-1.551103,"eighty":-0.480196,"marketCap":25456424},{"date":"2025-03-28","current":-1.487434,"twenty":-8.453115,"median":-1.55589,"eighty":-0.482636,"marketCap":20742272},{"date":"2025-04-04","current":-1.446868,"twenty":-8.42079,"median":-1.528001,"eighty":-0.483668,"marketCap":20176573},{"date":"2025-04-11","current":-1.27108,"twenty":-8.411844,"median":-1.519998,"eighty":-0.485697,"marketCap":17725214},{"date":"2025-04-17","current":-1.568567,"twenty":-8.391098,"median":-1.525203,"eighty":-0.486826,"marketCap":21873668},{"date":"2025-04-25","current":-1.744355,"twenty":-8.375981,"median":-1.528001,"eighty":-0.487258,"marketCap":24325028},{"date":"2025-05-02","current":-1.852532,"twenty":-8.369248,"median":-1.55589,"eighty":-0.487258,"marketCap":25833557},{"date":"2025-05-09","current":-1.663222,"twenty":-8.278077,"median":-1.568567,"eighty":-0.49069,"marketCap":23193631},{"date":"2025-05-16","current":-1.815301,"twenty":-8.203608,"median":-1.575039,"eighty":-0.493783,"marketCap":24325028},{"date":"2025-05-23","current":-1.913805,"twenty":-8.187149,"median":-1.582089,"eighty":-0.49432,"marketCap":25644990},{"date":"2025-05-30","current":-1.948554,"twenty":-8.178517,"median":-1.596287,"eighty":-0.495732,"marketCap":26110621},{"date":"2025-06-06","current":-1.887773,"twenty":-8.150735,"median":-1.606944,"eighty":-0.498765,"marketCap":25296161},{"date":"2025-06-13","current":-1.74476,"twenty":-8.067637,"median":-1.629032,"eighty":-0.500634,"marketCap":23379785},{"date":"2025-06-20","current":-1.74476,"twenty":-7.9813,"median":-1.636178,"eighty":-0.501381,"marketCap":23379785},{"date":"2025-06-27","current":-1.707005,"twenty":-7.916079,"median":-1.655456,"eighty":-0.501977,"marketCap":22873862},{"date":"2025-07-03","current":-1.658952,"twenty":-7.780139,"median":-1.658952,"eighty":-0.504359,"marketCap":22229960},{"date":"2025-07-11","current":-1.658952,"twenty":-7.697713,"median":-1.658952,"eighty":-0.52119,"marketCap":22229960},{"date":"2025-07-18","current":-1.616048,"twenty":-7.199911,"median":-1.658952,"eighty":-0.533159,"marketCap":21655047},{"date":"2025-07-25","current":-1.558843,"twenty":-6.568553,"median":-1.653661,"eighty":-0.554344,"marketCap":20888497},{"date":"2025-08-01","current":-1.53024,"twenty":-6.54427,"median":-1.644651,"eighty":-0.557875,"marketCap":20505222},{"date":"2025-08-08","current":-1.387229,"twenty":-6.337865,"median":-1.636178,"eighty":-0.557875,"marketCap":18588865},{"date":"2025-08-15","current":-1.283257,"twenty":-6.228591,"median":-1.629691,"eighty":-0.564937,"marketCap":17195640},{"date":"2025-08-22","current":-1.54853,"twenty":-6.107176,"median":-1.627269,"eighty":-0.567559,"marketCap":18312912},{"date":"2025-08-29","current":-1.491663,"twenty":-6.088434,"median":-1.624963,"eighty":-0.571556,"marketCap":17640403},{"date":"2025-09-05","current":-1.334185,"twenty":-6.025722,"median":-1.616048,"eighty":-0.57191,"marketCap":15778073},{"date":"2025-09-12","current":-1.334185,"twenty":-5.961478,"median":-1.606272,"eighty":-0.574823,"marketCap":15778073},{"date":"2025-09-19","current":-1.150461,"twenty":-5.949191,"median":-1.602755,"eighty":-0.575548,"marketCap":13605355},{"date":"2025-09-26","current":-1.093594,"twenty":-5.89102,"median":-1.587565,"eighty":-0.575553,"marketCap":12932847},{"date":"2025-10-03","current":-1.181082,"twenty":-5.808495,"median":-1.579827,"eighty":-0.578359,"marketCap":13967475},{"date":"2025-10-10","current":-1.474165,"twenty":-5.742931,"median":-1.573144,"eighty":-0.579452,"marketCap":17433478},{"date":"2025-10-17","current":-1.434796,"twenty":-5.682224,"median":-1.568567,"eighty":-0.581983,"marketCap":16967895},{"date":"2025-10-24","current":-1.272944,"twenty":-5.670082,"median":-1.560677,"eighty":-0.583355,"marketCap":15053834},{"date":"2025-10-31","current":-1.303565,"twenty":-5.611803,"median":-1.558843,"eighty":-0.586744,"marketCap":15415954},{"date":"2025-11-07","current":-1.128589,"twenty":-5.538954,"median":-1.557278,"eighty":-0.590741,"marketCap":13346698},{"date":"2025-11-14","current":-1.115466,"twenty":-5.51467,"median":-1.546536,"eighty":-0.59154,"marketCap":13191504},{"date":"2025-11-21","current":-1.062974,"twenty":-5.44425,"median":-1.531032,"eighty":-0.594738,"marketCap":12570727},{"date":"2025-11-28","current":-1.599048,"twenty":-5.419967,"median":-1.53024,"eighty":-0.595537,"marketCap":16126403},{"date":"2025-12-05","current":-1.5075,"twenty":-5.40054,"median":-1.530636,"eighty":-0.595537,"marketCap":15203136},{"date":"2025-12-12","current":-1.440364,"twenty":-5.354403,"median":-1.53024,"eighty":-0.596244,"marketCap":14526073},{"date":"2025-12-19","current":-1.171822,"twenty":-5.30098,"median":-1.526236,"eighty":-0.597136,"marketCap":11817822},{"date":"2025-12-26","current":-1.147409,"twenty":-5.276697,"median":-1.522344,"eighty":-0.597644,"marketCap":11571618},{"date":"2026-01-02","current":-1.007034,"twenty":-5.269412,"median":-1.518648,"eighty":-0.598296,"marketCap":10155941},{"date":"2026-01-09","current":-1.098583,"twenty":-5.228131,"median":-1.513603,"eighty":-0.599676,"marketCap":11079208},{"date":"2026-01-16","current":-1.037551,"twenty":-5.060579,"median":-1.51187,"eighty":-0.600245,"marketCap":10463697},{"date":"2026-01-23","current":-1.043654,"twenty":-5.050865,"median":-1.50833,"eighty":-0.600245,"marketCap":10525248},{"date":"2026-01-30","current":-0.958208,"twenty":-5.014441,"median":-1.507043,"eighty":-0.600245,"marketCap":9663532},{"date":"2026-02-06","current":-0.88497,"twenty":-4.905167,"median":-1.503229,"eighty":-0.602394,"marketCap":8924918},{"date":"2026-02-09","current":-0.933979,"twenty":-4.894769,"median":-1.503229,"eighty":-0.602621,"marketCap":9419174}],"updateTime":1770802259868},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMMB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588056541","title":"BRIEF-Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2588056541","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588056541?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:47","pubTimestamp":1764683260,"startTime":"0","endTime":"0","summary":"BRIEF-Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial ResultsDec 2 (Reuters) - Chemomab Therapeutics Ltd CMMB.O:CHEMOMAB THERAPEUTICS ANNOUNCES NEBOKITUG PHASE 2 SPRING TRIAL RESULTS IN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA22H1BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"gpt_icon":0},{"id":"2588053437","title":"Chemomab Therapeutics Publishes Positive Phase 2 Results for Nebokitug in Primary Sclerosing Cholangitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2588053437","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588053437?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:00","pubTimestamp":1764680439,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd. announced the publication of results from its Phase 2 SPRING trial evaluating nebokitug in patients with primary sclerosing cholangitis  in the American Journal of Gastroenterology. The study found that nebokitug, an anti-CCL24 monoclonal antibody, was safe and well tolerated compared to placebo at 15 weeks, with no safety signals observed for up to 48 weeks of treatment. The results indicated dose-dependent biological activity, particularly in patients with moderate to advanced fibrosis. Chemomab Therapeutics plans to advance nebokitug into a Phase 3 registration trial. The results from the SPRING trial have already been published and presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therape","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDLbzMthX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","LU2095319765.USD","NDAQ","BK4139","CMMB","IE00B64PRP62.GBP","BK4112","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2585462586","title":"Chemomab Therapeutics CEO to Present at Oppenheimer Movers in Rare Disease Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2585462586","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585462586?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:00","pubTimestamp":1763989229,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd. will participate in Oppenheimer's Movers in Rare Disease Summit on December 11, 2025, at the Sofitel Hotel in New York City. Co-founder and CEO Adi Mor, PhD, is scheduled to present a corporate overview from 2:15 to 2:45 pm EST and will be available for one-on-one meetings with registered attendees. The summit will feature panels, presentations, and investor meetings focused on companies working in the rare disease space.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via GlobeNewswire  on November 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL9k2Wx9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD","LU0314104364.USD","BK4588","BK4112","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","IE00B3QW5Z07.USD","CMMB","LU2095319765.USD","NDAQ"],"gpt_icon":0},{"id":"2585145902","title":"Chemomab Therapeutics (CMMB) Gets a Buy from Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2585145902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585145902?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:35","pubTimestamp":1763732142,"startTime":"0","endTime":"0","summary":"In a report released today, Jeff Jones from Oppenheimer maintained a Buy rating on Chemomab Therapeutics, with a price target of $25.00. Jones cove...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/chemomab-therapeutics-cmmb-gets-a-buy-from-oppenheimer-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/chemomab-therapeutics-cmmb-gets-a-buy-from-oppenheimer-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMMB","BK4127","BK4139","OPY"],"gpt_icon":0},{"id":"2584134542","title":"BRIEF-Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2584134542","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584134542?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:13","pubTimestamp":1763644419,"startTime":"0","endTime":"0","summary":"BRIEF-Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate UpdateChemomab Therapeutics Ltd CMMB.O:CHEMOMAB THERAPEUTICS ANNOUNCES THIRD QUARTER 2025 FINANCIAL RE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nTUAQ13C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMMB","BK4139"],"gpt_icon":0},{"id":"2584134538","title":"Chemomab Therapeutics Ltd - Cash Runway Expected Through End of Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2584134538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584134538?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:00","pubTimestamp":1763643607,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nTUAQ13C5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMMB"],"gpt_icon":0},{"id":"2584310531","title":"Press Release: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2584310531","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584310531?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:00","pubTimestamp":1763643600,"startTime":"0","endTime":"0","summary":"--Nebokitug PSC Phase 3 Design Near Completion Following Positive FDA Feedback--. --Regulatory Alignment Advances, with EMA Guidance Supporting a Single Nebokitug Phase 3 Registration Trial Using a. Dr. Mor continued, \"We are also encouraged that at the recent AASLD 2025 conference, the PSC community, including KOLs, global clinical centers and patient advocates, voiced their support for the nebokitug Phase 3 design, along with their interest in participating in the trial. With a clear regulatory pathway to approval in the US, international regulatory alignment on key aspects of the Phase 3 trial design and increasing market interest, we are seeing growing recognition of nebokitug's potential to become the first disease-modifying therapy for this devastating condition. The limited number of ongoing PSC trials provides a unique opportunity to leverage our strong engagement with global PSC centers to advance our Phase 3 program rapidly and efficiently. In parallel, we are continuing disc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMMB","R","BK6053","BK4232","BK4022","BK4539","LENZ","BK4007","DM0.SI","BK4139","PSC"],"gpt_icon":0},{"id":"2581098029","title":"Chemomab Reports Positive Phase 2 Data for Nebokitug in Primary Sclerosing Cholangitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2581098029","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581098029?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434057,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd. announced that new clinical data from the Phase 2 SPRING trial of nebokitug in primary sclerosing cholangitis  will be presented at the American Association for the Study of Liver Disease  The Liver Meeting 2025 on November 10, 2025. The presentations will include results from the trial's open label extension, demonstrating nebokitug's favorable safety profile and consistent improvements in key inflammatory and fibrotic biomarkers over up to 48 weeks of treatment. Additional data will provide insights into nebokitug's macrophage-mediated mechanisms of action in PSC. All three presentations have been designated as Posters of Distinction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLrJcr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4112","IE00B3QW5Z07.USD","BK4139","LU0314104364.USD","LU2095319765.USD","NDAQ","CMMB","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2581093849","title":"Chemomab Announces Multiple Presentations at Aasld the Liver Meeting® 2025 Featuring Clinical Data From the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093849?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434008,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA3PCW9C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMMB"],"gpt_icon":0},{"id":"2561529400","title":"Chemomab Therapeutics Announces 1-for-4 Reverse ADS Split Effective August 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2561529400","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561529400?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:05","pubTimestamp":1755893150,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd. announced a ratio adjustment for its American Depositary Shares , changing the ratio from one ADS representing twenty ordinary shares to one ADS representing eighty ordinary shares. This one-for-four reverse ADS split will take effect on August 26, 2025. The company's shares will continue trading on the Nasdaq Capital Market under the ticker \"CMMB\" with a new CUSIP Number of 16385C203. Fractional shares resulting from the split will be aggregated and sold, with proceeds distributed to ADS holders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system oper","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDLbhVFtn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"gpt_icon":0},{"id":"2561548467","title":"Chemomab Therapeutics Ltd. to Present at H.C. Wainwright 27th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2561548467","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561548467?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:01","pubTimestamp":1755777677,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd., a clinical stage biotechnology company focusing on therapeutics for fibro-inflammatory diseases, is set to present at the H.C. Wainwright 27th Annual Global Investment Conference. The company's CEO, Dr. Adi Mor, will deliver a prerecorded corporate presentation, which will be available via webcast starting September 5, 2025, at 7:00 am ET. Additionally, Chemomab will host one-on-one investor meetings during the conference on September 8 and September 9, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via GlobeNewswire  on August 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL6MDz8v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4585","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","BK4588","LU2210149790.SGD","CMMB","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","IE00BGHQF748.EUR","BK4139"],"gpt_icon":0},{"id":"2559206954","title":"Chemomab Therapeutics Ltd - to Change Ads Ratio to 1:80 Ordinary Shares Effective August 26","url":"https://stock-news.laohu8.com/highlight/detail?id=2559206954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559206954?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:00","pubTimestamp":1755172804,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nTUA6TFBKF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMMB"],"gpt_icon":0},{"id":"2548688211","title":"Chemomab Therapeutics Ltd. Conducted Annual General Shareholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2548688211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548688211?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:06","pubTimestamp":1751400382,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd. held its annual general shareholders meeting on July 1, 2025. Shareholders approved the re-election of Dr. Nissim Darvish and Ms. Jill Quigley as Class I directors. They also approved a grant of restricted share units to Dr. Adi Mor, the Chief Executive Officer and Chief Scientific Officer. Additionally, Somekh Chaikin was re-appointed as the independent registered public accounting firm for the fiscal year ended December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL9fyr6s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"gpt_icon":0},{"id":"2547099814","title":"Chemomab Therapeutics Announces Positive Phase 2 Trial Results for Nebokitug, Advancing Towards Phase 3 for Primary Sclerosing Cholangitis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2547099814","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547099814?lang=en_us&edition=fundamental","pubTime":"2025-06-30 20:00","pubTimestamp":1751284816,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Announces Positive Phase 2 Trial Results for Nebokitug, Advancing Towards Phase 3 for Primary Sclerosing Cholangitis Treatment. Chemomab Therapeutics Ltd. has announced the presentation of positive Phase 2 clinical data for their investigational drug, nebokitug, at BSG Live'25, the annual scientific meeting of the British Society for Gastroenterology in Glasgow, UK. The data, from the SPRING trial, indicates that nebokitug is well-tolerated and associated with significant improvements in fibrotic and inflammatory biomarkers in patients with primary sclerosing cholangitis . These improvements suggest a potential slowing of disease progression. The findings support the advancement of nebokitug to a Phase 3 trial, positioning it as a potential first-in-class treatment for PSC. The results were presented by Professor Douglas Thorburn, the Principal Investigator of the SPRING trial.Disclaimer: This news brief was created by Public Technologies  using generative artific","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL94jmhZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","NDAQ","LU2095319765.USD","IE00BKPKM429.USD","BK4585","BK4139","CMMB","LU2210150020.SGD"],"gpt_icon":0},{"id":"2542581934","title":"Chemomab Therapeutics Secures FDA Alignment on CMC and Toxicology Milestones, Advancing Phase 3 Development of Nebokitug for PSC","url":"https://stock-news.laohu8.com/highlight/detail?id=2542581934","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542581934?lang=en_us&edition=fundamental","pubTime":"2025-06-11 20:01","pubTimestamp":1749643262,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Secures FDA Alignment on CMC and Toxicology Milestones, Advancing Phase 3 Development of Nebokitug for PSC. TEL AVIV, Israel, June 11, 2025 -- Chemomab Therapeutics Ltd. , a clinical stage biotechnology company, announced positive feedback from two recent meetings with the FDA, facilitating the advancement of their drug nebokitug into a Phase 3 clinical trial for Primary Sclerosing Cholangitis . The FDA has aligned with Chemomab on essential Chemistry, Manufacturing, and Controls  requirements, ensuring the quality and consistency of the drug supply, and has also agreed to allow non-clinical toxicology studies to proceed concurrently with the Phase 3 clinical trial. This regulatory progress supports the timely advancement of nebokitug's development program as Chemomab continues discussions with potential strategic partners.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL9QjQDs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4588","BK4585","BK4139","BK4112","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210149790.SGD","NDAQ","LU2210150020.SGD","IE00BKPKM429.USD","CMMB","LU2095319765.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}